CHWY reports Tuesday with the core tension unchanged from recent days — shorts have rebuilt to 9.6% of the free float, options traders lean constructive, and the analyst community is now openly divided on price targets heading into the same print.
The analyst picture has sharpened materially since the August 26 selloff. Raymond James raised its target to $28 while reiterating Outperform — a vote of confidence at a price near the stock's current $23.66. Mizuho moved the opposite way on the same day, cutting its target from $40 to $32 while keeping the Outperform rating, a signal that conviction on direction survived but the magnitude of the call contracted. Morgan Stanley had already trimmed to $37 from $42 on August 26, the day of the prior print. The mean target now sits near $30, about 28% above the current price, but the spread across individual targets is wide enough that the consensus number flatters the actual disagreement. Rosenblatt initiated at Neutral with a $25 target — barely above where the stock trades today — making it the most cautious new voice added to the register in recent weeks.
The bull and bear cases map directly onto two different reads of the same company. Bulls point to the autoship subscription base as a durable revenue engine, and increasingly to the veterinary clinic and pet healthcare build-out as a differentiator that neither Amazon nor Walmart can replicate quickly. Bears focus on macro headwinds compressing discretionary attachment and premiumization — the incremental spending that lifts average order values — and argue those forces offset any share gains the subscription platform produces. The EPS forward momentum score ranks at the 88th percentile, suggesting the earnings trajectory itself is strong. But the 90-day momentum score sits at just 20, reflecting the 28% year-to-date drawdown that has made the stock a harder hold.
The ownership register adds one notable datapoint. Canada Pension Plan Investment Board added nearly 15 million shares in the quarter through June — a genuinely large incremental position — bringing its stake to roughly 4.9% of shares. That sits alongside BC Partners' 43% anchor holding, which has been steadily declining from 46%. The insider activity over the past 90 days is almost entirely tax-withholding transactions (code F) with no open-market buying — no conviction signal in either direction from management.
The September 9 print tests whether the autoship engine is still compounding fast enough to justify the forward earnings recovery narrative, or whether macro pressure on pet discretionary spending is taking longer to abate than bulls assumed after the August 26 miss.
See the live data behind this article on ORTEX.
Open CHWY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
